Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Adjusted EBITDA was $177 million in 2024 compared to $50 million in 2023
Place all sharps immediately into an approved sharps bin after use
Within three days, the company saw its share price plunge 27% after delivering disappointing 2026 guidance, only to be blindsided a day later by telehealth platform HIMS launching a $49 Wegovy pill copy. For a brief moment, it looked as if regulatory arbitrage might permanently erode one of the most valuable moats in global pharma
Removing the lesion is a common solution
US$ 25.77
US$ 21.35
US$ 22.74
US$ 29.07
US$ 26.58
US$ 29.31
US$ 27.16
